Fibromyalgia - etiology, diagnosis and treatment including perioperative management in patients with fibromyalgia.

Fibromyalgia (FM) is considered a multifactorial disorder/syndrome with not fully understood etiology. Chronic generalized pain is the main symptom. A broad spectrum of factors is proposed to explain the etiology. Its multifactorial nature is inherently associated with challenges in diagnosis and therapy. Various evidence of etiology has been evaluated with the aim of establishing a novel therapeutic approach. The main issue in the diagnosis and management is to focus on the evaluation of strict diagnostic criteria to minimize under- and overdiagnosis. Fibromyalgia is a challenge for perioperative management because of the increased risk of possible complications and poorer outcomes, including postoperative pain chronification. The authors have proposed an up-to-date evaluation of perioperative management considering the current guidelines. Multimodal analgesia combined with tailored perioperative care is the most appropriate assessment. Interdisciplinary research with special interest in pain management, including perioperative medicine, seems to be the main theme for the future.

Reaction of bis[(2-chlorocarbonyl)phenyl] Diselenide with Phenols, Aminophenols, and Other Amines towards Diphenyl Diselenides with Antimicrobial and Antiviral Properties.

A reaction of bis[(2-chlorocarbonyl)phenyl] diselenide with various mono and bisnucleophiles such as aminophenols, phenols, and amines have been studied as a convenient general route to a series of new antimicrobial and antiviral diphenyl diselenides. The compounds, particularly bis[2-(hydroxyphenylcarbamoyl)]phenyl diselenides and reference benzisoselenazol-3(2H)-ones, exhibited high antimicrobial activity against Gram-positive bacterial species (Enterococcus spp., Staphylococcus spp.), and some compounds were also active against Gram-negative E. coli and fungi (Candida spp., A.niger). The majority of compounds demonstrated high activity against human herpes virus type 1 (HHV-1) and moderate activity against encephalomyocarditis virus (EMCV), while they were generally inactive against vesicular stomatitis virus (VSV).

Mediastinal and chest wall limitations to asymmetry of lung inflation.

The extent to which inflation of one lung increases pleural pressure around the contralateral lung could affect ventilatory function, e.g., after pneumonectomy or lung transplantation. The rise in contralateral pleural pressure is limited by mediastinal stiffness and other chest wall properties. To estimate these properties, we determined an elastance of asymmetric expansion (E(Asym)) in 20 supine adults undergoing thoracic surgery requiring endobronchial intubation. Esophageal pressure, measured with a balloon catheter, was used as an estimate of pleural pressure for determining chest wall elastance during symmetric inflation. Pressures measured in the left and right lung airways during sequential asymmetric inflations with known volumes were used to calculate E(Asym) and elastances of left and right lungs by using a four-element mathematical model. Elastances (means +/- SD) were 13.0 +/- 8.7 (E(Asym)), 14.0 +/- 7.0 (left lung), 12.2 +/- 6.1 (right lung), and 6.7 +/- 2.1 cmH(2)O/l (chest wall). E(Asym) was high in three patients with prior cardiac surgery or mediastinal radiation therapy, suggesting that mediastinal stiffening due to scarring and fibrosis reduced pressure transmission between hemithoraxes. Simulations with a previously published model showed that changes in E(Asym) in the range of values observed could substantially affect lung ventilation after single-lung transplantation for emphysema.